Search CAHR Abstracts

Epidemiology and public health – Oral presentations

Harm reduction strategies and injection drug use

[301] RISK FACTORS FOR HIV AMONG FEMALE AND MALE INJECTION DRUG USERS: DOES SEXUAL TRANSMISSION EXPLAIN WHY FEMALE IDUS ARE BEING DISPROPORTIONATELY AFFECTED BY HIV IN VANCOUVER?
PM Spittal, M Tyndall, K Li, N Laliberte, E Wood, K Craib, MV O’Shaughnessy, MT Schechter. Vancouver Injection Drug Study, British Columbia Centre for Excellence in HIV/AIDS, St Paul’s Hospital; University of British Columbia

[302] RISK INDICATORS FOR HIV AND HCV INFECTION AMONG INJECTING DRUG USERS IN REGINA, SASKATCHEWAN
Williamson NJ¹, Archibald CP¹, Rendall S², Hay K³, Findlater R². ¹Bureau of HIV/AIDS, STD and TB, Population and Public Health Branch, Health Canada; ²Regina Health District, Saskatchewan; ³University of Saskatoon, Saskatchewan

[303] RAPID ASSESSMENT, RESPONSE AND EVALUATION PROJECT: THE CONTEXT OF INJECTION DRUG USE IN VICTORIA, BC
Linda Poffenroth. Capital Health

[304] ESCALATING HIV AND HEPATITIS C RATES AND RISK BEHAVIOUR AMONG IDUs IN RUSSIA: RESULTS OF THE CANADA AIDS RUSSIA PROJECT
L Calzavara¹, A Yakovlev³, T Nikitina⁴, G Volkova², M Michalchenko², V Orekhovsky¹, V Saldahna². ¹HIV Social, Behavioural and Epidemiological Studies Unit, University of Toronto, Toronto, Ontario; ²Canada AIDS Russia Project (CARP), St Petersburg, Russia; ³Botkin Hospital, St Petersburg, Russia; ⁴Provincial AIDS Centre, Kaliningrad, Russia

[305] FAINT LIGHT ON THE HORIZON? TRENDS IN HIV PREVALENCE, INCIDENCE AND NEEDLE BORROWING AMONG INJECTION DRUG USERS PARTICIPATING IN THE survUDI STUDY
Michel Alary^1,2, Catherine Hankins^1,3,4, Raymond Parent¹, Lina Noël¹ and the SurvUDI Working Group. 1: Institut national de santé publique, Québec; 2: Groupe de recherche en épidémiologie, Hôpital du Saint-Sacrement du CHA, Québec; 3: Direction de la santé publique de Montréal-Centre, Montréal; 4: Department of Epidemiology and Stastistics, McGill University, Montréal

[306] PREVENTING OVERDOSE DEATHS AND THE SPREAD OF BLOOD-BORNE DISEASES AMONG INJECTION DRUG USERS: THE CASE FOR SAFER INJECTING ROOMS
Evan Wood, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, O’Shaughnessy MV, Schechter MT. British Columbia Centre for Excellence in HIV/AIDS/Department of Health Care and Epidemiology, University of British Columbia

[307] THE IMPACT OF LOW THRESHOLD METHADONE PROGRAMS IN ONTARIO: AN APPROACH TO REDUCE HIV RISK BEHAVIORS AMONG OPIATE DEPENDENT DRUG USERS
Peggy Millson¹, Laurel Challacombe¹, Ted Myers¹, Benedikt Fischer^1,2, Carol Strike², Paul Villeneuve³, Ron Shore⁴, Mary Pearson⁴, Shawn Hopkins⁵. 1. University of Toronto, Toronto, Ontario; 2. Centre for Addiction and Mental Health, Toronto, Ontario; 3. University of Ottawa, Ottawa, Ontario; 4. Keep Six Needle Exchange Program, Kingston, Ontario; 5. The Works Needle Exchange Program, Toronto, Ontario

[308] PATTERNS OF DRUG USE FOLLOWING THE INITIATION OF METHADONE MAINTENANCE TREATMENT
Mark W Tyndall, N Laliberte, P Spittal, K Li, M O’Shaughnessy, MT Schechter. Vancouver Injection Drug User Study, British Columbia Centre for Excellence in HIV/AIDS